It is well documented that many herbal/health supplements (collectively referred as supplements) interact with warfarin. This research aimed to study the prevalence and intake of supplements by SingHealth Polyclinics patients on warfarin, and their knowledge of and perception towards potential supplements-warfarin interactions.
INtrODUctION
Herbal/health supplements (collectively referred to as supplements) use in the world has become increasingly popular. In the United States of America (USA) alone, more than 15 million people consume supplements, and the amount spent on them cost more than US$34 billion annually, far exceeding the amount paid for visits to primary care physicians. Despite the paucity of scientific evidence supporting their safety or efficacy, and unsubstantiated healthcare claims for some of the supplements, widespread promotion in the popular media has fuelled increasing consumer demand for these supplements 1 .
It is well documented in studies that numerous supplements interact with warfarin and affect the patients' International Normalized Ratio (INR) [1] [2] [3] [4] [5] [6] [7] [8] [9] . In a study published in the USA in 2010, as many as 8 out of 10 of the most widely used supplements had been reported to interact with warfarin. Several of these were associated with significant changes in the INR 8 . Examples of supplements reported were cranberry, gingko, garlic, glucosamine, coenzyme Q10, essential fatty acids, ginseng and St John's Wort.
Due to the high prevalence of supplement intake that could interact with warfarin, healthcare professionals have an important role to play in educating patients who are on warfarin to be aware of the effects of such supplements on their anticoagulation therapy. Such pertinent knowledge provided to the patients will empower them to take on a more active role in the management of their medical conditions. This study sought to ascertain the prevalence of concurrent use of supplements that interact with warfarin by SingHealth Polyclinic (SHP) patients, based on a list of supplements known to interact with warfarin 11, 12 . It also aimed to assess their knowledge of and perceptions to such interactions. This will help to provide useful insights to tailor patient education for more effective patient empowerment. To date, no such local studies have been published.
MEtHODOLOGY
This multicentre study was conducted across 4 locations -Bedok, Bukit Merah, Pasir Ris and Tampines polyclinics -from April to June 2010.
Approval was obtained from the Central Institutional Review Board ethics committee before commencement of the study.
Patients who were on warfarin prescribed by SHP doctors were invited to take part in the study when they arrived at the pharmacy to fill their prescriptions. These patients were screened to assess eligibility for participation according to the inclusion and exclusion criteria set. Informed written consent was obtained for those who satisfied the criteria.
All eligible patients who consented to be part of the study answered an investigator-administered questionnaire comprising of the following sections:
 Demographics and disease profiles;  Indication for warfarin;  Supplements intake;
 Knowledge of interactions between supplements and warfarin;
 Source of knowledge and importance of knowing the interactions between supplements and warfarin;
 Importance of communication with healthcare professionals regarding the supplements intake.
The first 100 patients, who satisfied the criteria and gave their informed consent, were recruited into the study. All the patients recruited were asked to answer the investigator-administered questionnaire once. The results of the survey were analysed using SPSS software and MS Excel.
Inclusion and exclusion criteria
SHP patients who were above the age of 21 years, and were prescribed warfarin by SHP doctors at the point of recruitment, were eligible for the study.
Patients were excluded if they were unable to converse in English, Mandarin (including the various dialects) or Malay, or had difficulty understanding and answering the interviewer, or had other cognitive difficulties.
Statistical Analysis
Chi Square Test or Fisher's Exact Probability Test was performed on categorical data depending on the number of cells with expected frequency of 5 or less. Fisher's Exact Probability Test was carried out to investigate:
 The relationship between patients who were able to verbalise the supplements that could interact with warfarin and those who were informed by their healthcare professionals about such interactions;
 If there was an association between patients who claimed that they were not told about supplements-warfarin interactions by their healthcare providers and those on supplements who subsequently did not inform them;
 If there was a significant relationship between patients who attached importance to informing Proceedings of Singapore Healthcare  Volume 20  Number 2  2011 their healthcare professionals and those who actually did inform them.
rESULtS

Epidemiology and Demographics
A total of 100 patients (out of the 450 patients managed by the 4 polyclinics) were recruited for the study, of which 59 were males and 41 were females. The mean age was 65.4 ± 10.7 years old (Table 1) . Chinese, Malay and Indian made up 81%, 18% and 1% of the study sample respectively. Patients who had no education or had primary education collectively made up 66% of the patients recruited, whereas 34% had at least a secondary education and above.
The top 3 indications for patients on warfarin in SHP were atrial fibrillation, cerebrovascular disease and myocardial infarct. The majority of the patients self-administered the medication while only 2% were administered by caregivers.
Supplement Intake and Prevalence
A significant 42 out of 100 patients who were on warfarin concurrently took supplements. Out of these 42 patients, 26.2% were taking more than 1 interacting supplement at the same time. Traditional Chinese Medicines (including ginseng and cordyceps), omega-3 fatty acids and glucosamine were among the most common supplements consumed ( Table 2) . Traditional Chinese Medicines (TCM) topped the list with about 30% of all supplements intake by the patients who took part in the survey. TCM consumed by patients in this study not only include single herb preparations like ginseng or cordyceps, but also many types of multiple-herb concoctions.
Patients mostly took the supplements with the general desire for good health and wellness, as well as for disease treatment or prevention (Table 3a) . Patients who were not on any supplements cited seeing no necessity in taking them (40.3%) or were advised against taking by their healthcare professionals (30.8%) as the main reasons (Table 3b ).
Knowledge of Interaction and Information Source
Of all the patients surveyed, 83% felt that it was important to know the potential interactions of supplements with warfarin.
Up to 48% (48 out of 100) of the patients responded that they were not told about possible supplements interactions with warfarin by their healthcare professionals. The other 52% (52 out of 100) received their education mainly from their doctors, pharmacists and nurses (Table 4) .
When asked to verbalise any supplements that could interact with warfarin, only 11% (11 out of 100) of all patients surveyed were able to do so. Among these 11 patients, a significant majority (10 out of 11) were patients who were previously educated by their healthcare professionals on warfarin interactions versus those who were not informed (p<0.0083).
There were 58 patients who claimed that they would only start taking the supplements after actively gathering more information. The people whom these patients would most likely turn to were doctors, pharmacists and family members or friends, at 62.1%, 13.8% and 12.1% respectively.
Importance of Informing Healthcare Professionals
Twenty-four out of the 42 patients (57.1%) who concurrently took supplements did not inform their healthcare providers that they were doing so. Out of these 24 patients, half of them received education on warfarin-supplement interactions previously whilst the other half claimed that they were not told. Among those patients who did inform their healthcare providers (18 out of 42), 13 of them were previously educated about such interactions. However for this study, there was no association found between patients who claimed that they were not told about such interactions by their healthcare providers and those on supplements who subsequently did not inform them (p=0.2079).
Seventy-six per cent of all the patients surveyed felt that it was important to inform their healthcare professionals if they were on supplements.
Out of the 42 patients who were on supplements, 74% (31 out of 42) felt that it was important to inform their healthcare professionals with regards to their supplements use. However, 45% (14 out of 31) of them did not inform their healthcare professionals. Of the other 11 patients who felt it was not important to inform their healthcare professionals, 10 patients did not inform. Therefore, it was found that the correlation between the importance attached by patients to inform healthcare professionals about their supplements intake and their actual decision to inform their healthcare professionals was significant (p=0.0122).
Reasons cited by the patients who felt it was important to inform their healthcare professionals with regards to their supplements use were:
 The concern that these supplements might interact with their warfarin and affect their INR results (22.6%);
 The concern that the use of the supplements might have some negative impact on their health (38.7%);
 The belief that they should seek professional advice with regards to the use of supplements (38.7%).
Reasons provided by those who failed to inform despite knowing the importance of doing so were:
 The perception that since they felt well after taking the supplements, the supplements that they were consuming were safe (50.0%);
 The misconception that it was not important to inform their healthcare professionals since they were not asked (35.7%);
 The apprehension that their healthcare professionals might ask them to stop taking their supplements (7.1%);
 The perception that healthcare professionals were not knowledgeable or were not concerned about supplements uses (7.1%).
Knowledge about Possible consequences of Interaction
Thirty-seven per cent of all the patients recruited in the survey was able to verbalise the signs that may be associated with significant supplementswarfarin interactions. The more common symptoms cited were bleeding (55.1%), bruises (18.4%) and signs of stroke (14.3%) such as severe headache, dizziness or numbness.
DIScUSSION
This study, set in a local primary care setting, found the prevalence of patients in the sample who were on concurrent warfarin and supplements to be rather high at 42%. Close to 60% of these patients who were taking supplements, did not inform their healthcare professionals of their supplements use.
The finding was quite similar to the 70% figure quoted in a study conducted in the USA 6 , and it reinforces the need to delve deeper into the issues related to possible supplements-warfarin interactions in the local population. Besides, these patients tend to be elderly (mean age of 65.4 years), and therefore are more sensitive to warfarin due to factors such as lower body weight, reductions in liver and renal functions 7 .
Ginseng, cordyceps, omega-3 and glucosamine, which are easily available locally, together made up 45.5% of the supplements consumed. The high usage of these common supplements that could interact with warfarin and potentially affect anticoagulation therapy should be a matter of concern among healthcare professionals. Eliciting information on supplements intake of patients on anticoagulation therapy should routinely form part of the patient communication and care process.
This study also found that TCM topped the list of the commonly used supplements. Four TCM herbs (in their crude forms) are known to interact with warfarin. These are ginseng, cordyceps, dong guai and dan shen. In addition to TCM herbs in their crude forms, many other TCM products mentioned by patients in the study were Chinese could also help to identify TCM that could be safely consumed by patients on warfarin.
Healthcare professionals play an important role in advancing medication safety by educating the patients and equipping them with pertinent knowledge which empower them to take on a more active role in the management of their medical conditions. As reinforced in this study, patients who were previously educated on potential warfarin interactions tend to be able to verbalise the supplements that could interact with warfarin, unlike those who had never been educated on such interactions. This shows that the good work carried out by healthcare professionals in educating patients on warfarin needs to be continued and better still, to improve further to ensure that it can keep up pace with the ever advancing technology and research.
About every 1 in 2 patients (58%) in this study would verify with any information source before starting a new supplement. Although healthcare professionals were still their main information providers, a notably high percentage of patients (12.1%) would turn to family members and friends for advice. This finding is of great concern as wrong information may be conveyed to the patient and may therefore jeopardise optimisation of the patient's anticoagulation therapy. To encourage this group of patients to turn to their healthcare professionals for more reliable advice, more communication channels should be made accessible.
As mentioned earlier in the paper, close to 60% of the patients did not inform their healthcare professionals of their supplements use. This may pose challenges to the management of the patient's anticoagulation treatment and thus, worsen their health or treatment outcomes. Healthcare promotion authorities may be roped in to help promote disclosure and increase screening for supplement use.
Another solution to improve the reporting rate of supplements use by patients who are on anticoagulation therapy is to counsel patients on the importance of informing healthcare professionals whenever they are taking them. The result of this study showed that patients who felt it was important to inform their healthcare professionals were more likely to inform them. Transtheoretical Stages of Change Model 10 is one approach that healthcare professionals could utilise. As proposed by the model, healthcare professionals can educate patients in the pre-contemplation stage, who may be unaware of or do not believe in the importance of informing healthcare professionals of their supplements use, of the consequences that may arise from failure to do so. Similarly, warfarin patients in the contemplation stage may need reinforcement on the value of informing healthcare professionals of the concurrent use of supplements use (as well as the risks in not doing so) so as to induce them to inform healthcare professionals if they are taking supplements or thinking of starting supplements.
In addition, in order to ensure a more holistic approach to patient counselling, it is also important to address any reasons, concerns and reservations given by patients on why they failed to inform or withhold information on their supplements intake from their healthcare professionals despite understanding its importance. It is necessary to reduce or remove any barriers of communication, such as through showing interest in listening or respectful communication, between the patients and their healthcare professionals in order for such information to be forthcoming. For example, some patients held back information for the fear that their healthcare professionals might stop them from taking the supplements. Other patients wrongly perceived supplements as safe for consumption either because they felt no ill effects after taking them or because their healthcare professionals did not routinely question about their intake. Taylor et al also reported a similar finding 9 . These findings illustrate the need to raise awareness of healthcare professionals that some warfarin patients may be concurrently taking supplements that may interfere with their anticoagulation management. Also, they need to take on a more proactive role (via system improvement or at individual practitioner level) in eliciting information from their patients on supplement intakes, and to foster a better relationship and improved communication with their patients in order to bring across important information.
Patients' awareness of what signs to look out for due to supplements-warfarin interactions is an important part of patient self-management and safety. It is disturbing that only 37% of the Proceedings of Singapore Healthcare  Volume 20  Number 2  2011 patients in this study were able to do that. This could be due to a lack of counselling on the part of healthcare professionals or patients could have experienced memory lapse and forgotten this information over a period of time. Whatever the reason is, it is important to reinforce this aspect of anticoagulation therapy to the patients on a regular basis during consultations for the purpose of patient safety.
A limitation of this study was that patients with cognitive impairment were excluded. This was due to the difficulty in eliciting information from them, or possible misrepresentation of information by their family members or caregivers.
cONcLUSION
The high prevalence of concurrent intake of supplements that could interact with warfarin and the lack of knowledge of potential interactions with patients' anticoagulation therapy is a concern to healthcare professionals, as these may cause undesirable effects on patients' health. Healthcare professionals, who are the main information providers to the patients, play an important role in advancing medication safety by educating these patients on possible warfarin interactions, and the signs and symptoms to look out for due to such interactions or anticoagulation therapy. This study also highlighted TCM on which further research could be carried out to determine their potential for interference with anticoagulation therapy. 
